🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

Recruitingn/aAges 12 Years - anyAllHuashan Hospital
NCT05387369 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study was designed to analyze the efficacy and safety of Paxlovid for the treatment of COVID-19.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Participants who have a positive SARS-CoV-2 test result; * Participants who have one or more mild or moderate COVID-19 symptoms. Exclusion Criteria: * No specific exclusion criteria in this real world study.
💊

What it tests

  • Paxlovid
📍

Where

1 site
Huashan Hospital Affiliated to Fudan University
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy